Vol. 19 No. 4-2 (2015): Cell Technologies in Cardiology (Special Issue)
EXPERIMENTAL STUDIES

Development of cell technologies for design of cell contained vascular grafts

I. Zakharova
The Federal Research Center Institute of Cytology and Genetics, The Siberian Branch of the Russian Federation Academy of Sciences, 10 Lavrentieva Avenue, 630090 Novosibirsk, Russian Federation; Institute of Chemical Biology and Fundamental Medicine, The Siberian Branch of the Russian Federation Academy of Sciences, 8 Lavrentieva Avenue, 630090 Novosibirsk, Russian Federation; Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health Care of Russian Federation, 15 Rechkunovskaya St., 630055 Novosibirsk, Russian Federation
M. Zhiven'
The Federal Research Center Institute of Cytology and Genetics, The Siberian Branch of the Russian Federation Academy of Sciences, 10 Lavrentieva Avenue, 630090 Novosibirsk, Russian Federation; Institute of Chemical Biology and Fundamental Medicine, The Siberian Branch of the Russian Federation Academy of Sciences, 8 Lavrentieva Avenue, 630090 Novosibirsk, Russian Federation; Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health Care of Russian Federation, 15 Rechkunovskaya St., 630055 Novosibirsk, Russian Federation
Sh. Saaya
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health Care of Russian Federation, 15 Rechkunovskaya St., 630055 Novosibirsk, Russian Federation
A. Shevchenko
The Federal Research Center Institute of Cytology and Genetics, The Siberian Branch of the Russian Federation Academy of Sciences, 10 Lavrentieva Avenue, 630090 Novosibirsk, Russian Federation; Institute of Chemical Biology and Fundamental Medicine, The Siberian Branch of the Russian Federation Academy of Sciences, 8 Lavrentieva Avenue, 630090 Novosibirsk, Russian Federation; Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health Care of Russian Federation, 15 Rechkunovskaya St., 630055 Novosibirsk, Russian Federation
A. Strunov
The Federal Research Center Institute of Cytology and Genetics, The Siberian Branch of the Russian Federation Academy of Sciences, 10 Lavrentieva Avenue, 630090 Novosibirsk, Russian Federation
L. Ivanova
The Federal Research Center Institute of Cytology and Genetics, The Siberian Branch of the Russian Federation Academy of Sciences, 10 Lavrentieva Avenue, 630090 Novosibirsk, Russian Federation; Novosibirsk National Research State University, 2 Pirogova St., 630090 Novosibirsk, Russian Federation
A. Karpenko
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health Care of Russian Federation, 15 Rechkunovskaya St., 630055 Novosibirsk, Russian Federation
E. Pokushalov
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health Care of Russian Federation, 15 Rechkunovskaya St., 630055 Novosibirsk, Russian Federation
S. Zakiyan
The Federal Research Center Institute of Cytology and Genetics, The Siberian Branch of the Russian Federation Academy of Sciences, 10 Lavrentieva Avenue, 630090 Novosibirsk, Russian Federation; Institute of Chemical Biology and Fundamental Medicine, The Siberian Branch of the Russian Federation Academy of Sciences, 8 Lavrentieva Avenue, 630090 Novosibirsk, Russian Federation; Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health Care of Russian Federation, 15 Rechkunovskaya St., 630055 Novosibirsk, Russian Federation; Novosibirsk National Research State University, 2 Pirogova St., 630090 Novosibirsk, Russian Federation

Published 2016-01-14

Keywords

  • vascular tissue engineering,
  • endothelium,
  • smooth muscle cells,
  • extracellular matrix

How to Cite

Zakharova, I., Zhiven’, M., Saaya, S., Shevchenko, A., Strunov, A., Ivanova, L., Karpenko, A., Pokushalov, E., & Zakiyan, S. (2016). Development of cell technologies for design of cell contained vascular grafts. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 19(4-2), 43–54. https://doi.org/10.21688/1681-3472-2015-4-2-43-54

Abstract

A new protocol for production of functional endothelial and mural cells from human cardiac explants has been developed. The endothelial cells are characterized by the presence of mature endothelial markers: CD 31, VE-cadherin and VEGFR2. Functionally they could take up ac-LDL, form tube-like structure in matrigel, contains functional cytoplasmic microvesicles Weibel-Palade bodies, in cytoplasm microvesicles – metabolized form of acetylated low-density lipoprotein, form capillary-like structures in Matrigel and produces extracellular matrix. The smooth muscle cells expressed a specific marker aSMA and produces extracellular matrix. The derived cell populations exhibit functional properties in hindlimb ischemia model. It was shown that the endothelial and the smooth muscle cells retain their specific surface antigens and the ability to produce an extracellular matrix on polycaprolactone and polylactide-co-glycolide surfaces. These cells can be used to develop a vascular tissue-graft.

References

  1. Nemeno-Guanzon J.G., Lee S., Berg J.R., Jo Y.H., Yeo J.E., Nam B.M., Koh Y.-G., Lee J.I. Trends in tissue engineering for blood vessels // J. Biomed. Biotechnol. 2012. Vol. 2012. P. 956345.
  2. Duncan D.R., Breuer C.K. Challenges in translating vascular tissue engineering to the pediatric clinic // Vasc. Cell. 2011. Vol. 3. № 1. P. 23.
  3. Foster E.D., Kranc M.A. Alternative conduits for aortocoronary bypass grafting // Circulation. 1989. Vol. 79. № 6. Pt 2. P. I34–9.
  4. Klinkert P., Post P.N., Breslau P.J., van Bockel J.H. Saphenous vein versus PTFE for above-knee femoropopliteal bypass. A review of the literature // Eur. J. Vasc. Endovasc. Surg. 2004. Vol. 27. № 4. P. 357–62.
  5. Ogle B., Cascalho M., Platt J.L. Fusion of approaches to the treatment of organ failure // Am. J. Transplant. 2004. Vol. 4. Suppl 6. P. 74–7.
  6. Nugent H.M., Edelman E.R. Tissue engineering therapy for cardiovascular disease // Circ. Res. 2003. Vol. 92. № 10. P. 1068–78.
  7. Olausson M., Patil P.B., Kuna V.K., Chougule P., Hernandez N., Methe K., Kullberg-Lindh C., Borg H., Ejnell H., Sumitran-Holgersson S. Transplantation of an allogeneic vein bioengineered with autologous stem cells: a proof-of-concept study // Lancet (London, England). 2012. Vol. 380. № 9838. P. 230–7.
  8. Nerem R.M., Ensley A.E. The tissue engineering of blood vessels and the heart // Am. J. Transplant. 2004. Vol. 4. Suppl 6. P. 36–42.
  9. Pate M., Damarla V., Chi D.S., Negi S., Krishnaswamy G. Endothelial cell biology: role in the inflammatory response // Adv. Clin. Chem. 2010. Vol. 52. P. 109–30.
  10. Tara S., Rocco K.A., Hibino N., Sugiura T., Kurobe H., Breuer C.K., Shinoka T., Vessel bioengineering // Circ. J. 2014. Vol. 78. № 1. P. 12–9.
  11. Wang H., Zhou J., Liu Z., Wang C. Injectable cardiac tissue engineering for the treatment of myocardial infarction // J. Cell. Mol. Med. 2010. Vol. 14. № 5. P. 1044–55.
  12. L’Heureux N., McAllister T.N., de la Fuente L.M. Tissue-engineered blood vessel for adult arterial revascularization // N. Engl. J. Med. 2007. Vol. 357. № 14. P. 1451–3.
  13. Shin’oka T., Matsumura G., Hibino N., Naito Y., Watanabe M., Konuma T., Sakamoto T., Nagatsu M., Kurosawa H. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells // J. Thorac. Cardiovasc. Surg. 2005. Vol. 129. № 6. P. 1330–8.
  14. Rufaihah A.J., Huang N.F., Kim J., Herold J., Volz K.S., Park T.S., Lee J.C., Zambidis E.T., Reijo-Pera R., Cooke J.P. Human induced pluripotent stem cell-derived endothelial cells exhibit functional heterogeneity // Am. J. Transl. Res. 2013. Vol. 5. № 1. P. 21–35.
  15. Nolan D.J., Ginsberg M., Israely E., Palikuqi B., Poulos M.G., James D., Ding B.-S., Schachterle W., Liu Y., Rosenwaks Z., Butler J.M., Xiang J., Rafii A., Shido K., Rabbany S.Y., Elemento O., Rafii S. Molecular signatures of tissue-specific microvascular endothelial cell heterogeneity in organ maintenance and regeneration // Dev. Cell. 2013. Vol. 26. № 2. P. 204–19.
  16. Павлова С.В., Перовский П.П., Чепелева Е.В., Малахова А.А., Дементьева Е.В., Покушалов Е.А., Сухих Г.Т., Закиян С.М. Характеристика кардиальных культур клеток, полученных из экспланта сердечной мышцы человека // Клеточные технологии в биологии и медицине. 2013. № 3. С. 132–140
  17. Couffinhal T., Silver M., Zheng L.P., Kearney M., Witzenbichler B., Isner J.M., Mouse model of angiogenesis // Am. J. Pathol. 1998. Vol. 152. № 6. P. 1667–79.
  18. Yamahara K., Sone M., Itoh H., Yamashita J.K., Yurugi-Kobayashi T., Homma K., Chao T.-H., Miyashita K., Park K., Oyamada N., Sawada N., Taura D., Fukunaga Y., Tamura N., Nakao K. Augmentation of neovascularization [corrected] in hindlimb ischemia by combined transplantation of human embryonic stem cells-derived endothelial and mural cells // PLoS One. 2008. Vol. 3. № 2. P. e1666.
  19. Lai W.-H., Ho J.C.Y., Chan Y.-C., Ng J.H.L., Au K.-W., Wong L.-Y., Siu C.-W., Tse H.-F. Attenuation of hind-limb ischemia in mice with endothelial-like cells derived from different sources of human stem cells // PLoS One. 2013. Vol. 8. № 3. P. e57876.
  20. S.H. Bhang, Lee S., Lee T.-J., La W.-G., Yang H.-S., Cho S.-W., Kim B.-S. Three-dimensional cell grafting enhances the angiogenic efficacy of human umbilical vein endothelial cells // Tissue Eng. 2012. Part A. Vol. 18. № 3–4. P. 310–9.
  21. Chan B.P., Leong K.W. Scaffolding in tissue engineering: general approaches and tissue-specific considerations // Eur. Spine J. 2008. Vol. 17. Suppl 4. P. 467–79.
  22. Rosenbaum A.J., Grande D.A., Dines J.S. The use of mesenchymal stem cells in tissue engineering: A global assessment // Organogenesis. 2008. Vol. 4. № 1. P. 23–7.